Pancreatic cancer patients with germline BRCA mutations can benefit from olaparib treatment
Transl Cancer Res
.
2020 Apr;9(4):2154-2156.
doi: 10.21037/tcr.2020.03.07.
Authors
Shibani Mukherjee
1
,
Aroumougame Asaithamby
1
Affiliation
1
Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
PMID:
35117572
PMCID:
PMC8798592
DOI:
10.21037/tcr.2020.03.07
No abstract available
Publication types
Editorial
Comment